NEW YORK (360Dx) – The New York State Department of Health is planning to stop conducting drug susceptibility testing for tuberculosis isolates that are determined to be pan-susceptible through whole-genome sequencing.
The move, which NYSDOH says it is able to do because of the accuracy and the comprehensiveness of its whole-genome sequencing data, is expected to save time and money, and free staff to explore other areas of tuberculosis testing that have not been as thoroughly investigated, according to lab officials.